Is there still a role for prostatic acid phosphatase? CSCC position statement1 1 This document has been reviewed by two independent reviewers on behalf of Clinical Biochemistry. In addition, it has been reviewed and endorsed by the following individual clinical biochemists: TC Dembinski (Winnipeg), M D’Costa (Toronto), LC Dymond (Halifax), AW Luxton (Hamilton), C Prosser (Edmonton), M Pudek (Vancouver), W Schneider (Montreal), and PY Wong (Toronto). Some of their laboratories have already stopped measuring PAP, and report very few requests for the test. 2 2 The Prostate Cancer Alliance of Canada, an organization that arose out of the National Prostate Cancer Forum of 1997, also reviewed this Position Statement, and stated in April 1999: “Prostatic acid phosphatase (PAP) no longer has a role in the diagnosis, screening or staging of prostate cancer.” The membership of the Alliance includes representatives from the following national organizations: Canadian Association for Nurses in Oncology, Canadian Association of Radiation Oncologists, Canadian Association of Radiologists, Canadian Cancer Society, Canadian Prostate Cancer Network, Canadian Prostate Cancer Research Foundation, Canadian Urology Association, Canadian Uro-Oncology Group, College of Family Physicians of Canada, Division of Aging and Seniors, Health Canada, National Cancer Institute of Canada, and Princess Margaret Hospital.
Title:
Is there still a role for prostatic acid phosphatase? CSCC position statement1 1 This document has been reviewed by two independent reviewers on behalf of Clinical Biochemistry. In addition, it has been reviewed and endorsed by the following individual clinical biochemists: TC Dembinski (Winnipeg), M D’Costa (Toronto), LC Dymond (Halifax), AW Luxton (Hamilton), C Prosser (Edmonton), M Pudek (Vancouver), W Schneider (Montreal), and PY Wong (Toronto). Some of their laboratories have already stopped measuring PAP, and report very few requests for the test. 2 2 The Prostate Cancer Alliance of Canada, an organization that arose out of the National Prostate Cancer Forum of 1997, also reviewed this Position Statement, and stated in April 1999: “Prostatic acid phosphatase (PAP) no longer has a role in the diagnosis, screening or staging of prostate cancer.” The membership of the Alliance includes representatives from the following national organizations: Canadian Association for Nurses in Oncology, Canadian Association of Radiation Oncologists, Canadian Association of Radiologists, Canadian Cancer Society, Canadian Prostate Cancer Network, Canadian Prostate Cancer Research Foundation, Canadian Urology Association, Canadian Uro-Oncology Group, College of Family Physicians of Canada, Division of Aging and Seniors, Health Canada, National Cancer Institute of Canada, and Princess Margaret Hospital.
Journal description